Waters Corporation (NYSE: WAT) Reports Third Quarter 2026 Financial Results
PR Newswire•03/11/2026•06:00 ET
0
Key Highlights
- ➤Q3 revenue $1.767 billion, exceeding guidance midpoint by $14 million
- ➤Adjusted EPS $4.10, up 21% year over year and above guidance
- ➤Full-year revenue guidance raised $43 million at the midpoint
- ➤Full-year adjusted EPS guidance raised to $14.60-$14.70
- ➤Waters acquired MOBILion Systems to expand its proteomics market entry
Expert Statements
Udit Batra, President and Chief Executive Officer of Waters Corporation
“Our team delivered exceptional results led by best-in-class consumables growth across both our Analytical Sciences and Biosciences divisions, as strong execution, new product innovation, and rising customer testing volume accelerated growth.”
Udit Batra, President and Chief Executive Officer of Waters Corporation
“LC-MS instrument growth also strengthened, growing double-digits in constant currency, driven by robust instrument replacement trends, idiosyncratic growth drivers across GLP-1s, PFAS and India generics, and we continued to outperform the market with our leading solutions for complex biologics.”
Udit Batra, President and Chief Executive Officer of Waters Corporation
“Thanks to the hard work of our teams, we are delivering ahead of schedule on our synergy and integration commitments for our acquired businesses.”
Udit Batra, President and Chief Executive Officer of Waters Corporation
“With improving end market conditions and momentum accelerating across the combined company, we are raising our full year 2026 revenue guidance by $43 million at the midpoint and our fourth quarter guidance calls for double digit growth in both our organic and acquired businesses on a days adjusted basis.”
Waters Corporation (NYSE: WAT) Reports Third Quarter 2026 Financial Results PR Newswire
Company to Provide Starting 2027 Growth Framework on Earnings Conference Call
Get started
Create a free account to read the full story.